This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories (ABT) stock has slipped roughly 13% year-to-date, a pullback that has caught the attention of income-focused investors. The healthcare giant has a record of more than five decades of dividend growth and continues to post steady business expansion across several segments. With a forward dividend yield of about 2.2%, compared to the healthcare sector average of roughly 1.6%, Abbott may be appealing to passive income investors looking for stability in this volatile market. So, does this dip represent a buying opportunity? More News from Barchart Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. www.barchart.com A Rare Dividend King in Healthcare Valued at roughly $190 billion, Abbott Labs is a global healthcare company that develops and sells medical devices, diagnostic tests, nutrition products, and branded generic medicines used to diagnose, monitor, and
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Diabetes And Cardiology Updates Test Growth Story For Investors [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India [Yahoo! Finance]Yahoo! Finance
- Invesco Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website